Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study.

Shaji K. Kumar, MD, Amrita Krishnan, MD, Vivek Roy, M.D., Todd M Zimmerman, MD, Morie Abraham A Gertz, MD, Keith E. Stockerl-Goldstein, MD, Francis K Buadi, M.D., Cara Rosenbaum, MD, Ann Birgin, CRA, Mark Fiala, BS, CCRP, Valeria Jiminez, Michele Maharaj, RN, Michael N. Needle, MD, Ravi Vij, MD

Blood (2012) 120 (21): 2965.

https://doi.org/10.1182/blood.V120.21.2965.2965

Published: 2012

Journal Articles

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.

John A Lust, MD, PhD, Saad Z Usmani, MD FACP, Mehdi Hamadani, MD, Charles Barranco, Martha Q Lacy, MD, Angela Dispenzieri, MD, Morie A Gertz, David Dingli, M.D., Ph.D., Stephen Russell, MD, PhD, Francis K Buadi, M.D., Steven R Zeldenrust, MD, PhD, Suzanne R Hayman, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, John Thompson, Catherine A Taylor, Richard Dondero

Blood (2012) 120 (21): 2973.

https://doi.org/10.1182/blood.V120.21.2973.2973

Published: 2012

Journal Articles

Doxycycline Used As Post Transplant Antibacterial Prophylaxis Improves Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Stem Cell Transplantation.

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Marina Ramirez-Alvarado, Ph.D., Prashant Kapoor, MD, William Hogan, MD, S. Vincent Rajkumar, MD, Morie A Gertz

Blood (2012) 120 (21): 3138.

https://doi.org/10.1182/blood.V120.21.3138.3138

Published: 2012

Journal Articles

Outcomes of Patients with POEMS Syndrome Treated Initially with Radiation

Michael Humeniuk, M.D., Morie A. Gertz, M.D., Martha Q. Lacy, MD, Robert A. Kyle, MD, Suzanne R. Hayman, MD, Shaji K. Kumar, MD, John A. Lust, MD, PhD, Thomas E. Witzig, MD, Francis K. Buadi, M.D., S. Vincent Rajkumar, MD, Steven R. Zeldenrust, MD, PhD, Stephen J. Russell, MD, PhD, David Dingli, M.D., Ph.D., Yi Lin, MD, Prashant Kapoor, MD, Nelson Leung, MD, Angela Dispenzieri, MD

Blood (2012) 120 (21): 448.

https://doi.org/10.1182/blood.V120.21.448.448

Published: 2012

Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Myeloma: Long Term Follow up and Factors Predicing Outcome in 345 Patients

Blood (2012) 120 (21): 201.

https://doi.org/10.1182/blood.V120.21.201.201

Published: 2012

Journal Articles

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Girindra G Raval, MD, Morie A Gertz, Martha Q Lacy, MD, Suzanne R Hayman, MD, Shaji K. Kumar, MD, Francis K Buadi, M.D., John A. Lust, MD, PhD, Steven Zeldenrust, MD, David Dingli, M.D., Ph.D., Robert L Hall, RN, CNP, Lisa Hwa, RN, CNP, Yi Lin, MD, Prashant Kapoor, MD, Thomas E. Witzig, MD, Robert A. Kyle, MD, Stephen Russell, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2012) 120 (21): 946.

https://doi.org/10.1182/blood.V120.21.946.946

Published: 2012

Journal Articles

Importance of Achieving Sustained Stringent Complete Response (sCR) Following Autologous Stem Cell Transplantation in Multiple Myeloma

Prashant Kapoor, MD, Morie A Gertz, M.D., Angela Dispenzieri, MD, Martha Q Lacy, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, Francis K Buadi, M.D., Stephen Russell, MD, PhD, Yi Lin, MD, Thomas E. Witzig, MD, John A Lust, MD, PhD, Steven R Zeldenrust, MD, PhD, Philip R. Greipp, MD, Robert A. Kyle, MD, Vincent Rajkumar, MD, Shaji K. Kumar, MD

Blood (2012) 120 (21): 1988.

https://doi.org/10.1182/blood.V120.21.1988.1988

Published: 2012

Journal Articles

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A Gertz, Martha Q Lacy, MD, John A Lust, MD, PhD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Stephen Russell, MD, PhD, Prashant Kapoor, MD, Yi Lin, MD, PhD, Lisa Hwa, RN, CNP, Dirk Larson, Colin L. Colby, Joanne T Benson, Robert A. Kyle, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 3972.

https://doi.org/10.1182/blood.V120.21.3972.3972

Published: 2012

Journal Articles

Renal Heavy Chain and Heavy+Light Chain Amyloidosis: A Report of 17 Cases and Comparison with Renal Light Chain Amyloidosis

Samih H. Nasr, Samar M. Said, Anthony M. Valeri, Sanjeev Sethi, Lynn D. Cornell, Mary E. Fidler, Morie Abraham A Gertz, MD, Angela Dispenzieri, MD, Francis K Buadi, M.D., Julie A Vrana, Ph.D., Jason D Theis, Ahmet Dogan, MD, PhD, Nelson Leung, MD

Blood (2012) 120 (21): 3992.

https://doi.org/10.1182/blood.V120.21.3992.3992

Published: 2012

Journal Articles

Patients with Immunoglobulin Light Chain Amyloidosis (AL) Undergoing High Dose Chemotherapy with Autologous Stem Cell Transplantation (ASCT) have Superior Outcomes As Compared to Patients with Multiple Myeloma (MM)

Kirupananthan Seenithamby, Angela Dispenzieri, MD, Martha Q Lacy, MD, Shaji K. Kumar, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., Mark R Litzow, MD, Dennis A. Gastineau, MD, David J. Inwards, MD, Ivana N. Micallef, MD, Stephen M. Ansell, M.D., Ph.D., Patrick B. Johnston, MD, PhD, Luis F. Porrata, MD, Mrinal M. Patnaik, MBBS, MD, William J Hogan, MBBCh, Morie Abraham A Gertz, MD

Blood (2012) 120 (21): 600.

https://doi.org/10.1182/blood.V120.21.600.600

Published: 2012

Journal Articles

Refinement in Patient Selection to Reduce Treatment-Related Mortality From Stem Cell Transplantation in Amyloidosis

Morie A Gertz, Martha Q Lacy, MD, Angela Dispenzieri, MD, Shaji K. Kumar, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, William J Hogan, MBBCh, Francis K Buadi, M.D., Suzanne R Hayman, MD

Blood (2012) 120 (21): 599.

https://doi.org/10.1182/blood.V120.21.599.599

Published: 2012

Journal Articles

Outcomes and Treatments of Relapsed AL Amyloidosis Following Stem Cell Transplant

Rahma Warsame, MD, Soo-Mee Bang, MD, PhD, Shaji K. Kumar, MD, Martha Q Lacy, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, John A Lust, MD, PhD, Stephen Russell, MD, PhD, Thomas E. Witzig, MD, Robert A. Kyle, MD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, S. Vincent Rajkumar, Morie A Gertz, Angela Dispenzieri, MD

Blood (2012) 120 (21): 1858.

https://doi.org/10.1182/blood.V120.21.1858.1858

Published: 2012

Journal Articles

Relapse of POEMS Following Autologous Stem Cell Transplantation: A Single Center Experience

Anita D'Souza, MBBS, MD, Francis K Buadi, M.D., Martha Q Lacy, MD, Morie A Gertz, MD, Suzanne R Hayman, MD, Shaji Kumar, MD, David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD

Blood (2011) 118 (21): 3101.

https://doi.org/10.1182/blood.V118.21.3101.3101

Published: 2011

Journal Articles

Matched Case Control Analysis Comparing Long Term Survival of Multiple Myeloma Patients Who Received Stem Cell Transplant with and without Idiotype-Pulsed Dendritic Cell Vaccine

Yi Lin, MD PhD, Morie A Gertz, MD, Robert B. Sims, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Betsy LaPlant, Angela Dispenzieri, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Douglas Padley, Dennis A. Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, MD, Martha Q Lacy, MD

Blood (2011) 118 (21): 636.

https://doi.org/10.1182/blood.V118.21.636.636

Published: 2011

Journal Articles

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Evangelos Terpos, Meletios Athanasios Dimopoulos, MD, Stephanie Harel, MD, Francis K Buadi, M.D., Dimitrios Christoulas, Ersi Voskaridou, Efstathios Kastritis, Jean Paul Fermand, MD, Angela Dispenzieri, MD

Blood (2011) 118 (21): 806.

https://doi.org/10.1182/blood.V118.21.806.806

Published: 2011

Journal Articles

Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of 225 Patients Treated in Five Cohorts Over Three Years,

Blood (2011) 118 (21): 3963.

https://doi.org/10.1182/blood.V118.21.3963.3963

Published: 2011

Journal Articles

Factors Predicting Early Mortality in Patients with Newly Diagnosed Multiple Myeloma,

Vishal Rana, MBBS, Geetika Srivastava, MBBS, Suzanne R Hayman, MD, Francis K Buadi, M.D., Morie A Gertz, MD, Martha Q Lacy, MD, Philip R. Greipp, MD, Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Robert A Kyle, MD, John A Lust, MD, PhD, Kristen Detweiler Short, N.P, David Dingli, M.D., Ph.D., Stephen J. Russell, S. Vincent Rajkumar, Shaji Kumar, MD

Blood (2011) 118 (21): 3981.

https://doi.org/10.1182/blood.V118.21.3981.3981

Published: 2011

Journal Articles

The Timing of Acute Renal Failure Strongly Affects Survival of Immunoglobulin Light Chain (AL) Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation,

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis A. Gastineau, MD, Siobhan V Glavey, M.B., B. Ch, Morie A Gertz, MD

Blood (2011) 118 (21): 4120.

https://doi.org/10.1182/blood.V118.21.4120.4120

Published: 2011

Journal Articles

Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy

Shaji Kumar, MD, Joseph R. Mikhael, MD, Martha Q Lacy, MD, Betsy R. LaPlant, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Morie A Gertz, MD, Teresa Miceli, RN, Marcia Mahlman, P.Leif Bergsagel, MD, Suzanne R Hayman, MD, Craig B. Reeder, MD, Angela Dispenzieri, MD, Dennis A. Gastineau, MD, Jeffrey Winters, MD

Blood (2011) 118 (21): 2992.

https://doi.org/10.1182/blood.V118.21.2992.2992

Published: 2011

Journal Articles

Survival Outcome of Young Multiple Myeloma (MM) Patients in the Era of Novel Therapies

Prashant Kapoor, MD, Morie A Gertz, MD, S. Vincent Rajkumar, MD, Martha Q Lacy, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, Stephen J. Russell, John A Lust, MD, PhD, Francis K Buadi, M.D., Steven R Zeldenrust, Philip R. Greipp, MD, Angela Dispenzieri, MD, Robert A Kyle, MD, Shaji Kumar, MD

Blood (2011) 118 (21): 2950.

https://doi.org/10.1182/blood.V118.21.2950.2950

Published: 2011

NARROW

Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study.

Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.

Doxycycline Used As Post Transplant Antibacterial Prophylaxis Improves Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Stem Cell Transplantation.

Outcomes of Patients with POEMS Syndrome Treated Initially with Radiation

Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Myeloma: Long Term Follow up and Factors Predicing Outcome in 345 Patients

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Importance of Achieving Sustained Stringent Complete Response (sCR) Following Autologous Stem Cell Transplantation in Multiple Myeloma

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Renal Heavy Chain and Heavy+Light Chain Amyloidosis: A Report of 17 Cases and Comparison with Renal Light Chain Amyloidosis

Patients with Immunoglobulin Light Chain Amyloidosis (AL) Undergoing High Dose Chemotherapy with Autologous Stem Cell Transplantation (ASCT) have Superior Outcomes As Compared to Patients with Multiple Myeloma (MM)

Refinement in Patient Selection to Reduce Treatment-Related Mortality From Stem Cell Transplantation in Amyloidosis

Outcomes and Treatments of Relapsed AL Amyloidosis Following Stem Cell Transplant

Relapse of POEMS Following Autologous Stem Cell Transplantation: A Single Center Experience

Matched Case Control Analysis Comparing Long Term Survival of Multiple Myeloma Patients Who Received Stem Cell Transplant with and without Idiotype-Pulsed Dendritic Cell Vaccine

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of 225 Patients Treated in Five Cohorts Over Three Years,

Factors Predicting Early Mortality in Patients with Newly Diagnosed Multiple Myeloma,

The Timing of Acute Renal Failure Strongly Affects Survival of Immunoglobulin Light Chain (AL) Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation,

Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy

Survival Outcome of Young Multiple Myeloma (MM) Patients in the Era of Novel Therapies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only